Where buyer urgency comes
- Buyer urgency often arises from regulatory deadlines, major platform migrations, and market consolidation pressures. - Practical examples cited include platform waves like Veeva compressing life-sciences sales cycles and decision timelines. - The guidance is to manage existing urgency signals rather than manufacture them to maintain deal momentum. ( )
Buyer urgency usually starts outside the sales call: a legal deadline, a platform shutdown, or a merger clock that forces a decision by a date certain. (fda.gov) (ftc.gov) (veeva.com) In life sciences software, Veeva’s migration wave is a clear example. Veeva said on March 3, 2026 that more than 125 customers are already live on Vault CRM, and it moved the end-of-support date for legacy Veeva CRM up from September 2030 to December 2029. (veeva.com) Salesforce is pitching the same deadline from the other side. A Salesforce migration brief says pharma and biotech customers will need to choose between Veeva Vault CRM and Salesforce Life Sciences Cloud starting in September 2025, with all transitions completed by September 2030. (salesforce.com) That kind of timetable compresses buying behavior because the work is not just a software purchase. A customer has to budget, migrate data, retrain field teams, validate workflows, and avoid running a commercial system past its support window. (veeva.com 1) (veeva.com 2) (salesforce.com) Regulatory deadlines create the same pressure. The Food and Drug Administration said the Drug Supply Chain Security Act requires interoperable, electronic tracing of prescription drugs at the package level, and it granted a one-year stabilization period from November 27, 2023 to November 27, 2024 to help trading partners implement those systems. (fda.gov 1) (fda.gov 2) When a manufacturer, wholesaler, or dispenser faces a compliance date, the urgency is already real before any vendor outreach begins. The seller’s job is usually to map the product to the deadline, not invent a new reason for the buyer to move. (fda.gov 1) (fda.gov 2) Market consolidation adds another clock. The Federal Trade Commission said certain mergers and acquisitions must be reported before closing under the Hart-Scott-Rodino Act, and the 2026 adjusted threshold for the basic size-of-transaction test is $133.9 million, effective February 17, 2026. (ftc.gov) (ftc.gov) After a deal is announced, duplicate systems rarely survive for long. Combined companies typically face a fixed integration window for customer data, reporting lines, and vendor contracts, which can pull software evaluations forward by quarters instead of years. (ftc.gov) (salesforce.com) The Veeva case shows why these moments feel faster than ordinary budget cycles. Veeva put its Salesforce-based CRM into stability mode after the final functional release in December 2023, while Salesforce said its own sales-automation offering for pharma and biotech customers would not be available for sale until after September 1, 2025. (veeva.com) (salesforce.com) That leaves buyers managing a narrow sequence: keep the current system running, pick a future platform, and complete migration work before support or commercial terms change. In those windows, urgency comes from the calendar the buyer already has. (veeva.com) (salesforce.com)